A Randomized Comparative Study of Efficacy of Lamivudine and Adefovir Combination versus Tenofovir versus Entecavir in Decompensated Cirrhotic Patients of Hepatitis B-Advanced Research in Gastroenterology & Hepatology-Juniper Publishers

JUNIPER PUBLISHERS-Advanced Research in Gastroenterology & Hepatology

A RANDOMIZED COMPARATIVE STUDY OF EFFICACY OF LAMIVUDINE AND ADEFOVIR COMBINATION VERSUS TENOFOVIR VERSUS ENTECAVIR IN DECOMPENSATED CIRRHOTIC PATIENTS OF HEPATITIS B

Authored by Pathik Parikh

Decompensation is a frequent presentation of Hepatitis B related liver disease. In India transplantation is not easily available. Hence antiviral drugs form the backbone of management. Lamivudine and Adefovir, either as alone or as combination has been useful, Entecavir and tenofovir have good efficacy. These drugs have different side effect, resistance and cost profile which is important considering long term treatment.

For Read More... Fulltext click on: https://juniperpublishers.com/argh/ARGH.MS.ID.555553.php

For More Articles in Advanced Research in Gastroenterology & Hepatology Please Click on:
https://juniperpublishers.com/argh/index.php

For More Open Access Journals In Juniper Publishers Please Click on:
https://juniperpublishers.com/index.php

 

Comments

Post a Comment

Popular posts from this blog

A Modified Sequential Regimen of Helicobacterpylori Treatment Enforced by Bacillus clausii and Zinc Carnosine Complex Yields High Eradication Rates_Juniper Publishers

Image
  ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS   Authored by Dajani AI      Abstract Introduction: Over the past decade a worldwide trend of decline in the cure rates of Helicobacter pylori is observed. Current eradication rates achieved by the standard triple therapy are below 70%. Sequential therapy had provided a potential alternative that would compensate for the unmet performance of triple therapy. Despite its superiority to triple therapy, the excellent results reported initially were not reproduced by other investigators work. Adding adjuvant agents was also found to improve further the success rate of eradication. Probiotics emerged as a useful adjunct in treatment and prophylaxis of Helicobacter pylori infection. The nutritional supplement Zinc carnosine complex is another adjuvant which is believed to add value to the treatment. Patients and method: an open label randomized observational clinical study ...
Read more

A Novel Over-The-Scope Clip (OTSC) For the Treatment of Severe Non-Variceal Upper GI-Bleeding: An Alternative to Classic Hemostatic Techniques?_Juniper Publishers

Image
ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS     Authored by Wedi E Abstract Gastrointestinal bleeding is a frequent endoscopic emergency. The mortality rate, due to non-variceal upper gastrointestinal bleeding (NVUGB), remains despite technical advances between 5-10%. Conventional endoscopic treatment includes through the scope clips (TTSC), injection therapy and thermal therapy. The over-the-scope-clip (OTSC) is a novel endoscopic device, that overcomes limitations of standard clips and achieves a more efficient and reliable haemostasis in non-variceal upper gastrointestinal bleeding (NVUGIB). His review article gives an overview of the recently published data on this topic and discusses future perspectives in GI-bleeding management. Keywords: Endoscopy; Non-variceal upper gi bleeding; Over-the-scope clip; OTSC Introduction Gastrointestinal bleeding is frequent in clinical practice ...
Read more

Pancreatic Adenocarcinoma: Current Therapies and Challenges

Image
ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS Authored by Myron R Szewczuk  Abstract Gastrointestinal (GIJ cancer is an all-encompassing term that refers to the forms of cancers of the digestive system including the esophagus, liver, gallbladder, stomach, small intestine, colon, rectum, anus and pancreas. Of the cancers mentioned, pancreatic ductal adenocarcinoma (PDACJ is the most deadly form of GI cancer owing partially to the late detection of this malignancy. At this point of diagnosis, the disease has metastasized and very few treatment options are available to patients. The aggressive nature of this cancer can be attributed to the substantial number of mutations acquired during its progression and its subsequent resistance to standard therapies such as chemotherapy and radiationThe heterogeneity of the subpopulations that are chemoresistant, particularly the tumor initiating population as known as cancer stem cells...
Read more